"Fundada l'any 1900, MútuaTerrassa és una entitat de benefici social que té per missió el servei a les persones, anticipant i resolent situacions i problemes relacionats amb la salut, l'autonomia personal o el seu benestar. Actua en l'àmbit geogràfic fonamentalment de Catalunya i en algunes activitats a tot el territori espanyol."

During the past decade, Hospital Mutua de Terrassa conducted 109 clinical trials. In the 10-year time frame, 109 clinical trials started and 37 clinical trials were completed, i.e. on average, 33.9% percent of trials that started reached the finish line to date. In the past 5 years, 47 clinical trials started and 30 clinical trials were completed. i.e. 63.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Mutua de Terrassa" #1 sponsor was "Pfizer" with 11 trials, followed by "Spanish Breast Cancer Research Group" with 11 trials sponsored, "Hospital Mutua de Terrassa" with 10 trials sponsored, "PETHEMA Foundation" with 10 trials sponsored and "Janssen Research & Development, LLC" with 10 trials sponsored. Other sponsors include 115 different institutions and companies that sponsored additional 93 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Mutua de Terrassa" #1 collaborator was "Hospital Mutua de Terrassa" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 4 trials as a collaborator, "AstraZeneca" with 3 trials as a collaborator, "Hoffmann-La Roche" with 3 trials as a collaborator and "Pfizer" with 3 trials as a collaborator. Other collaborators include 134 different institutions and companies that were collaborators in the rest 126 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Mutua de Terrassa" are "Breast Cancer" (12 trials), "Multiple Myeloma" (8 trials), "Alzheimer Disease" (6 trials), "Alzheimer's Disease" (5 trials) and "Coronary Artery Disease" (4 trials). Many other conditions were trialed in "Hospital Mutua de Terrassa" in a lesser frequency.

Most popular intervention types in "Hospital Mutua de Terrassa" are "Drug" (101 trials), "Other" (25 trials), "Procedure" (16 trials), "Device" (10 trials) and "Biological" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Lenalidomide" (8 trials), "Cyclophosphamide" (6 trials), "Dexamethasone" (6 trials) and "placebo" (6 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Mutua de Terrassa" are 146 trials for "All" genders, 20 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Hospital Mutua de Terrassa". 2 are not yet recruiting, 25 are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 90 completed trials in Hospital Mutua de Terrassa, 2 suspended trials, and 22 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Mutua de Terrassa, 4 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 60 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 18 trials that are defined as “Not Applicable".

Hospital Mutua de Terrassa has several departments that took part in Clinical trials: "Hospital Mutua De Terrasa; Servicio de Neurologia" - 7 trials, "Hospital Mutua de Terrassa Servicio de Oncologia" - 4 trials, "Hospital Mutua de Terrassa; Servicio de Hematologia" - 3 trials, "ES-Barcelona-MUTUATERRASSA" - 2 trials